1-20 of 146
Blood Spotlight
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

TP53 -mutated acute myeloid leukemia: how can we improve outcomes?

Available to Purchase
Clinical Trials & Observations
David A. Sallman, Maximilian Stahl
Journal: Blood
Blood (2025) 145 (24): 2828–2833.
https://doi.org/10.1182/blood.2024024245
Published: 2025
Journal Articles

Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in adults over 70 years old

Available to Purchase
Roland B. Walter, Victoria Potter, Charles Craddock
Journal: Blood
Blood (2025) 145 (24): 2847–2856.
https://doi.org/10.1182/blood.2024024247
Published: 2025
Journal Articles

Approaching a therapeutic inflection point for FLT3 -mutated AML

Available to Purchase
Clinical Trials & Observations
Alexander E. Perl
Journal: Blood
Blood (2025) 145 (24): 2834–2839.
https://doi.org/10.1182/blood.2024024248
Published: 2025
Journal Articles

The fit older adult with acute myeloid leukemia: clinical challenges to providing evidence-based frontline treatment

Available to Purchase
Sameem Abedin, Geoffrey L. Uy, Laura C. Michaelis
Journal: Blood
Blood (2025) 145 (24): 2840–2846.
https://doi.org/10.1182/blood.2024026004
Published: 2025
Journal Articles

Emerging biomarkers for CD3×CD20 bispecific antibodies in lymphoma

Available to Purchase
Cameron S. Lewis, Allison Barraclough, Eliza A. Hawkes
Journal: Blood
Blood (2025) 145 (17): 1850–1857.
https://doi.org/10.1182/blood.2024025772
Published: 2025
Journal Articles

Impact of new medications on the treatment of immune TTP

Available to Purchase
Marie Scully, Lara Howells, William A. Lester
Journal: Blood
Blood (2025) 145 (13): 1353–1357.
https://doi.org/10.1182/blood.2024026390
Published: 2025
Journal Articles

Novel mechanisms of resistance in CLL: variant BTK mutations in second-generation and noncovalent BTK inhibitors

Available to Purchase
Constantine S. Tam, Shalini Balendran, Piers Blombery
Journal: Blood
Blood (2025) 145 (10): 1005–1009.
https://doi.org/10.1182/blood.2024026672
Published: 2025
Journal Articles

FDA-approved therapies for chronic GVHD

Available to Purchase
Stephanie J. Lee, Robert Zeiser
Journal: Blood
Blood (2025) 145 (8): 795–800.
https://doi.org/10.1182/blood.2024026633
Published: 2025
Journal Articles

Menin inhibitors in the treatment of acute myeloid leukemia

Available to Purchase
Gerwin Huls, Carolien M. Woolthuis, Jan Jacob Schuringa
Journal: Blood
Blood (2025) 145 (6): 561–566.
https://doi.org/10.1182/blood.2024026232
Published: 2025
Journal Articles

Imetelstat: a new addition to the therapeutic landscape of lower-risk MDS

Available to Purchase
Clinical Trials & Observations
Yasmin Abaza, Amy E. DeZern
Journal: Blood
Blood (2025) 145 (5): 469–474.
https://doi.org/10.1182/blood.2024025702
Published: 2025
Includes: Supplemental data
Journal Articles

Building the future management of follicular lymphoma with T-cell–redirecting strategies

Available to Purchase
Clinical Trials & Observations
Gloria Iacoboni, Franck Morschhauser
Journal: Blood
Blood (2025) 145 (2): 170–175.
https://doi.org/10.1182/blood.2024025699
Published: 2025
Includes: Supplemental data
Journal Articles

Momelotinib for the treatment of myelofibrosis

Available to Purchase
Prithviraj Bose
Journal: Blood
Blood (2024) 144 (7): 708–713.
https://doi.org/10.1182/blood.2023023719
Published: 2024
Journal Articles

BCMA- or GPRC5D-targeting bispecific antibodies in multiple myeloma: efficacy, safety, and resistance mechanisms

Free
Holly Lee, Paola Neri, Nizar J. Bahlis
Journal: Blood
Blood (2024) 143 (13): 1211–1217.
https://doi.org/10.1182/blood.2023022499
Published: 2024
Includes: Supplemental data
Journal Articles

“Treatment with curative intent”: the emergence of genetic therapies for sickle cell anemia

Free
Edward J. Benz, Jr., Leslie E. Silberstein, Julie Panepinto
Journal: Blood
Blood (2024) 143 (11): 967–970.
https://doi.org/10.1182/blood.2023021598
Published: 2024
Journal Articles

Recent developments in the use of pyruvate kinase activators as a new approach for treating sickle cell disease

Free
Dina S. Parekh, William A. Eaton, Swee Lay Thein
Journal: Blood
Blood (2024) 143 (10): 866–871.
https://doi.org/10.1182/blood.2023021167
Published: 2024
Journal Articles

CAR T-cell therapy in multiple myeloma: mission accomplished?

Free
Leo Rasche, Michael Hudecek, Hermann Einsele
Journal: Blood
Blood (2024) 143 (4): 305–310.
https://doi.org/10.1182/blood.2023021221
Published: 2024
Journal Articles

Macrophage heterogeneity in the single-cell era: facts and artifacts

Free
David A. Hume, Susan M. Millard, Allison R. Pettit
Journal: Blood
Blood (2023) 142 (16): 1339–1347.
https://doi.org/10.1182/blood.2023020597
Published: 2023
Journal Articles

Pirtobrutinib: a new hope for patients with BTK inhibitor–refractory lymphoproliferative disorders

Free
Clinical Trials & Observations
Philip A. Thompson, Constantine S. Tam
Journal: Blood
Blood (2023) 141 (26): 3137–3142.
https://doi.org/10.1182/blood.2023020240
Published: 2023
Includes: Supplemental data
Journal Articles

Tumor microenvironment contribution to checkpoint blockade therapy: lessons learned from Hodgkin lymphoma

Free
Antonino Carbone, Annunziata Gloghini, Carmelo Carlo-Stella
Journal: Blood
Blood (2023) 141 (18): 2187–2193.
https://doi.org/10.1182/blood.2022016590
Published: 2023
Journal Articles

Vaccine-induced immune thrombotic thrombocytopenia

Free
Douglas B. Cines, Andreas Greinacher
Journal: Blood
Blood (2023) 141 (14): 1659–1665.
https://doi.org/10.1182/blood.2022017696
Published: 2023